 |
|
Lee is a biotech industry angel
investor and entrepreneur, a role he has held since graduating with a doctor of
medicine degree from the Albert Einstein College of Medicine in 2008. Lee has
worked jointly with Wolfgang Oster for the past two years as an entrepreneur,
executive and fellow board member. Prior to attending medical school,
Lee spent more than 19 years in the
financial industry at a number of major Wall Street firms, including Morgan
Stanley, J.P. Morgan, Credit Suisse and Banc of America Securities. From 1985 to
1993 he was an investment banker and raised billions in capital for public and
private firms. From 1993 to 2004, he served as a research analyst and authored
more than 1,000 reports covering more than 50 different publicly-traded
companies and earned a reputation for groundbreaking research.
He currently serves on the board
of Oncoceutics, a drug discovery and development company focused on
development of novel anti-cancer compounds, ImmunoGenes, a biopharmaceutical
company specialized in the generation of transgenic animals for the production
of polyclonal and monoclonal antibodies, and the Juvenile Diabetes Research
Foundation - New York Chapter, a non-profit dedicated to finding a cure for
diabetes and its complications through research.
Lee holds a doctor of medicine
degree from the Albert Einstein College of Medicine in New York, and he is a
summa cum laude graduate of the University of Pennsylvania where he earned dual
degrees from the University's Wharton School and College of Arts and Sciences.
|
